ATXS – astria therapeutics, inc. (US:NASDAQ)

Sec Filings

Form 425 Astria Therapeutics, Filed by: BIOCRYST PHARMACEUTICALS INC
Form SCHEDULE 13G/A Astria Therapeutics, Filed by: Vestal Point Capital, LP
Form SCHEDULE 13G/A Astria Therapeutics, Filed by: ForGrowth III PA B.V.
Form 10-Q Astria Therapeutics, For: Sep 30
Form 8-K Astria Therapeutics, For: Nov 12
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com